Novavax on Thursday deferred its target to become profitable by a year to 2028 as changes in U.S. vaccination policy have ...
Fed officials say debt downgrade complicates inflation outlook, Nvidia CEO discusses China chip ban, JPMorgan’s investor day, and more news to start your day. Biotech Regeneron already faces enough of ...
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
The Biden administration announced Monday that it would purchase 3.2 million doses of the Novavax COVID-19 vaccine. It will be offered at no cost to states and federal partners. “We remain committed ...
Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12. The Maryland-based company makes a protein-based vaccine that's been cleared for use in adults in parts of the ...
Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, ...
Q3 2025 Earnings Call Transcript November 6, 2025 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 ...
The COVID-19 vaccine rollout in 2025 is shaping up to be significant different than in past years. The U.S. Food and Drug Administration has approved updated vaccines under new guidelines, but the U.S ...
NEW YORK — Americans headed to pharmacies for covid-19 vaccines are running into roadblocks and confusion due to new U.S. guidance that abandoned broad support for the shots, contributing to the ...
Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback